Mark Walters
Division Chief of Hematology · University of California (San Francisco) School of Medicine
Credentials: · ·
History
- Present
Hematology Division · University of California (San Francisco) School of Medicine
- Present
Division of Hematology · University of California (San Francisco) School of Medicine
- 1988–1990
University of Washington School of Medicine GME
- 1981–1985
- 1977–1981
University of California
Research
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
New England Journal of Medicine · 2018 · 520 citations
Bone marrow transplantation for sickle cell disease
New England Journal of Medicine · 1996 · First of 12 authors · 449 citations
Blood · 2017 · 375 citations
20 papers
20 papers
- SS
16 papers
- LK
15 papers
14 papers
13 papers
- JT
12 papers
- JK
11 papers
Grants
- 2023–2028
National Institute of Diabetes and Digestive and Kidney Diseases · TL1
PI · $5.1M · University of California, San Francisco
- 2015–2023
National Heart, Lung, and Blood Institute · U01
PI · $7.3M · Yale University
- 2019–2021
Curing Sickle Cell Disease with CRISPR-Cas9 Genome Editing
National Heart, Lung, and Blood Institute · OT2
Contact PI · $2.2M · University of California, San Francisco
- 2011–2016
Hematopoietic Cell Therapy for Young Adults with Severe Sickle Cell Disease
National Heart, Lung, and Blood Institute · R34
PI · $734.3K · Emory University
Clinical trials
- 2025–2030
Principal investigator · Recruiting · Phase 1, Phase 2
Mark Walters, MD
- 1999–2006
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
Study chair · Completed · Phase 2
National Heart, Lung, and Blood Institute (NHLBI)
- 2001–2007
Induction of Stable Chimerism for Sickle Cell Anemia
Completed · Phase 2
National Heart, Lung, and Blood Institute (NHLBI)